Biolase, Inc. - BIOL Short-Term Debt to Capital

BIOL (BIOLASE, Inc.) - company brandmark

BIOLASE, Inc. (BIOL) generates revenue from the sale of dental lasers via a high-margin consumables model, utilizing automated lines for precision optical assembly. This chart illustrating the price evolution of the quotes on GURU.Markets shows the metric at 0.00. Patent protection and customer loyalty ensure stability within a niche segment, although limited demand constrains the brand's expansion rate.

BIOL - BIOLASE Inc. Short-Term Debt to Equity Ratio over the range 07/04/2022 - 08/04/2024

Analytical breakdowns for BIOLASE, Inc.

- stock value and consensus price forecast:
Price Chart Biolase, Inc.|BIOL - Forecast Levels Chart
- issuer market value details:
Market Capitalization BIOLASE Inc.|BIOL - Total Enterprise Value
- book capitalization information:
Book Value per Share BIOLASE|BIOL - Company Net Assets|Market Capitalization to Book Value Ratio biolase.com|BIOL - Company Total Asset Base
- debt level and financial liquidity data:
Total Debt to Capital BIOLASE, Inc.|BIOL - Long-Term Debt to Capital|Short-Term Debt to Equity BIOLASE|BIOL - Company Debts|Debts to Book Capitalization BIOLASE Inc.|BIOL - Long-Term Debt Volume|Company Current Liabilities BIOLASE
General company analysis:Biolase, Inc.
Brand item of BIOLASE

Stable component supplies for BIOLASE dental lasers enable the optimization of working capital, while the short-term debt-to-equity ratio measures the proportion of short-term liabilities (over one year) within the capital structure, identifying risks of shareholder value dilution and assessing the balance between debt financing and financial stability to prevent liquidity gaps.

Main competitors

Short-Term Debt to Equity Boston Scientific Inc (BSX)|EW: Current Liabilities to Equity|Short-Term Debt to Capital RMD (ResMed Inc.)|insulet.com (PODD) - Current Liabilities to Capital|Zimmer Biomet Holdings - Short-Term Debt to Capital|The Cooper Companies, Inc. (COO) - Short-Term Debt to Equity Ratio|ALGN: Short-Term Debt to Capital|GMED - Short-Term Debt to Capital Coefficient|TMDX (TransMedics Group Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital atecspine.com|Short-Term Debt to Equity Artivion (AORT)|Short-Term Debt to Equity ENOV (Enovis Corp)|Short-Term Debt to Capital IART (Integra)|Short-Term Debt to Capital Coefficient Establishment Labs Inc (ESTA)|BBNX: Short-Term Debt to Equity Ratio|Current Liabilities to Equity IRMD|EMBC: Short-Term Debt to Capital|Current Liabilities to Capital Tandem Diabetes Care Inc (TNDM)|AXGN (Axogen Corp) - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio SIBN (SI-BONE Medical)|Short-Term Debt to Equity Ratio OFIX (Orthofix Medical Inc.)|BVS (bioventus.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity OrthoPediatrics KIDS|TMCI - Short-Term Debt to Equity Ratio|Strata Critical Medical Corp - Short-Term Debt to Capital|Current Liabilities to Capital Carlsmed Medical|RXST: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio CLPT|STXS (Stereotaxis) - Short-Term Debt to Capital|Neuronetics Inc. (STIM) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital SGHT|Short-Term Debt to Equity Ratio orchestrabiomed.com OBIO|Short-Term Debt to Capital ANIK (Anika Therapeutics, Inc.)|Short-Term Debt to Capital inspiremd.com NSPR|ZJYL - Short-Term Debt to Equity|VANI: Short-Term Debt to Equity|XTNT (xtantmedical.com) - Short-Term Debt to Equity Ratio|NeuroOne Medical Technologies Corp. - Ratio of Short-Term Indebtedness to Capital|MODD (Modular Medical Inc) - Short-Term Debt to Capital|Current Liabilities to Capital myomo.com MYO|Short-Term Debt to Equity Envoy Medical (COCH)|Vivos Therapeutics Inc. (VVOS) - Short-Term Indebtedness to Equity|enVVeno - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Sintx Technologies Inc SINT|Tenon Medical, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient rewalk.com LFWD|autonomix.com (AMIX) - Short-Term Debt to Equity|Current Liabilities to Equity IVF (INVO Bioscience)|Short-Term Debt to Equity Bone Biologics Corporation|Short-Term Debt to Equity Ratio Axonics, Inc (AXNX)|Short-Term Debt to Capital DYNT|FNA - Current Liabilities to Capital|Short-Term Debt to Equity INVO Bioscience INVO